Neo-adjuvant radiotherapy and chemotherapy in the clinical application of advanced esophageal cancer.doc
- 1、本文档共10页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Neo-adjuvant radiotherapy and chemotherapy in the clinical application of advanced esophageal cancer
PAGE \* MERGEFORMAT 10
Neo-adjuvant radiotherapy and chemotherapy in the clinical application of advanced esophageal cancer
【Abstract】 Objective To investigate the neo-adjuvant oral UFT (UFT) over the same period hyperfractionated radiotherapy for advanced esophageal cancer near, long-term efficacy. Preoperative clinical stage of stage Ⅱ, Ⅲ, no radiotherapy and chemotherapy, surgery contraindications 147 cases of esophageal cancer patients group. Study group 51 cases, preoperative oral UFT350mg / m 2 · d, for 2 weeks, at the same time hyperfractionated radiation therapy, each dose of 1.5Gy, 2 times a day, with a total dose of 30Gy, radiation therapy 2 to 4 weeks after the end of surgery. Control group, 96 cases, preoperative have not been. Two pairs of cases close to long-term results were compared. Outcomes research group, the control group of radical resection rate was 86.27%, 69.79%; Study Group tumor stage, postoperative local recurrence rate than the control group was significantly lower; operative time, blood loss, after the first 1 chest drainage, postoperative complications, no significant difference between the two groups. Study group in the 3,5-year survival rates were 53.25%, 36.87% in the control group 3,5-year survival rates were 43.49%, 25.37%. KM survival curve differences between the two groups had no significant (P = 0.1001), but the study group was compared with non-remission in patients with remission were significantly increased (P = 0.0206). Conclusion Over the same period of oral UFT hyperfractionated radiotherapy can reduce the tumor stage, local recurrence rate, and improve short-term effect; to the improvement of long-term survival is not yet clear, but the ease of patients received significantly improve long-term survival.
Keywords: Esophageal cancer chemotherapy, external radiotherapy Neoadjuvant therapy
application study of neoadjuvant chemoradiotherapyfor locallyadvancedesophageal carcinoma
您可能关注的文档
- National health care products companies direct path.doc
- National drug emblica immunomodulatory effect of freeze-dried powder of serum pharmacology.doc
- National Medicinal Plants of the basic structure of an early warning system.doc
- National Medicinal Plants of the basic structure of an early warning system_0.doc
- National journal of medical informatics literature.doc
- National drunk driving crackdown pushing non-alcoholic beer Yanjing.doc
- National Pits 1573- Tough and protect the price of war.doc
- National strict regulation pharmaceutical companies how to do-.doc
- National policy even behind the popularity of LCD TVs war broke out in rural areas.doc
- National sporting goods companies- the beauty of channels of injury conceal the brand practicing internal force is benevolent side.doc
文档评论(0)